SPH Notice – FMR LLC

Disclosure of ceasing to have substantial holding Section 279, Financial Markets Conduct Act 2013 Note: This form must be completed in accordance with the instructions at the end of the form. To New Zealand Stock Exchange and To Ryman Healthcare Ltd. Date this disclosure made: 18 Oct 2018 Date last disclosure made: 14 May 2018 Date on which substantial holding ceased: 16 Oct 2018 Substantial product holder(s) giving disclosure Full name(s): FMR LLC and the entities listed in Annexure A ("FMR") Summary of previous substantial holding Class of quoted voting products: Ordinary Shares Summary for FMR LLC For last disclosure,-- (a) total number held in class: 33,662,403 (b) total in class: 500,000,000 (c) total percentage held in class: 6.73% For current holding after ceasing to have substantial holding,-- (a) total number held in class: 23,662,393 (b) total in class: 500,000,000 (c) total percentage held in class: 4.73% Details of transactions and events giving rise to ceasing of substantial holding Details of the transactions or other events requiring disclosure: See attached for Table. Additional information Address(es) of substantial product holder(s): Refer to annexure A Contact details: Jen Li, Head of Regulatory Reporting, FIL Asia Holdings Pte Limited, +852 2629 2657 Name of any other person believed to have given, or believed to be required to give, a disclosure under the Financial Markets Conduct Act 2013 in relation to the financial products to which this disclosure relates: N/A Certification I, Jen Li, certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. End CA:00325517 For:RYM Type:SHINTR Time:2018-10-19 08:30:16